HEICO Corporation (NYSE: HEI / HEI.A) — A Best-in-Class Aftermarket Compounder Priced for Permanence, With a 25%-Cheaper Door In

Independent Equity Research Analyst: Claude (AI Research Analyst) | Date: 2026-06-14 Price (2026-06-12): HEI $331.61 (Common, 1 vote) · HEI.A $247.09 (Class A, 1/10 vote — identical economics, ~25% cheaper) Market cap: ~$39.1B | Net debt: ~$1.95B | EV: ~$41.1B | Shares: ~55.1M Common + ~84.3M Class A = ~139.4M Sector: Industrials — Aerospace & Defense (aftermarket parts + electronics) | FY-end: Oct 31 | CIK: 0000046619

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only. It is not investment advice. The analysis that follows takes no position and carries no price target — this block is the one exception.

Verdict: HOLD the business; if you buy it, buy HEI.A, not HEI. A wonderful compounder at a full price, with a structural 25%-off coupon hiding in the share-class structure. Conviction: medium.

HEICO is one of the highest-quality compounding machines in US industrials — and the market knows it. The Flight Support Group sells FAA-approved (PMA) replacement parts at ~25–50% below OEM list, a moat built not on pricing power (that’s TransDigm’s game) but on a regulatory-approval portfolio of 19,500+ parts, deep customer trust (~75 million parts shipped with zero airworthiness directives), and a cost advantage the OEMs cannot retaliate against without torching their own spares profit pool. Bolt that to a 35-year, ~100-deal serial-acquisition flywheel — niche aerospace/electronics businesses bought ~80%, with founders kept on as put-right-incentivized owner-operators — and you get a ~20%-per-share compounder that turned $1.79B of FY2020 revenue into $4.49B by FY2025, with organic growth accelerating (FSG +19% / ETG +17% organic in Q2 FY2026, net income +49%). The founder-succession risk that hung over the name for years has now passed cleanly: Laurans Mendelson died in September 2025, and sons Eric and Victor — who already ran the two segments — stepped up as Co-CEOs with the culture and super-voting control intact.

The catch is price. At ~30x EV/EBITDA and ~68x earnings (on HEI), HEICO has no valuation cushion: on its own ten-year history it sits at only the ~58th percentile — i.e., it has been “expensive forever,” and is merely mid-range-expensive today, not cheap-versus-itself. It trades at a ~40% EV/EBITDA premium to TransDigm despite half the EBITDA margin and a lower ROIC (~13%). The price embeds mid-teens compounding for a decade and the continuation of the M&A flywheel at ever-larger scale — a demanding bar where a stumble (FSG organic fading toward mid-single digits and an M&A drought) gets punished twice, by lower earnings and a de-rate. So I can’t call the common stock a bargain. But here is the sharp point: HEI.A carries the identical dividend and the identical claim on earnings as HEI — the only difference is 1/10th of a vote that a minority holder can’t use anyway given family control — and it trades at $247 versus $332, a ~25% discount (P/E ~50x vs ~68x). For an economic-only investor, paying up 25% for a vote you’ll never exercise is the one clearly avoidable mistake here. Own the cash flows through HEI.A.

Framing: quality-compounder-at-a-full-price, with a share-class arbitrage. The tag: a great business, and a 25%-off coupon stapled to it. Conviction: medium. Bullish trigger (would flip me to accumulate even the common): evidence the M&A flywheel keeps turning at scale — sustained low-double-digit organic plus disciplined sub-15x-EBITDA bolt-ons that hold ROIC ≥13%. Bearish trigger: two-plus quarters of FSG organic decelerating below ~6% alongside a visible M&A slowdown — the flywheel stalling is the one thing the ~30x multiple cannot survive.

1. Executive Summary

HEICO Corporation is a founder-family-controlled aerospace, defense, and electronics company that has compounded shareholder capital at roughly 20% per year for three-plus decades through a distinctive two-engine model: a high-return aftermarket parts franchise and a disciplined serial-acquisition flywheel. FY2025 (ended October 2025) revenue was $4,485M, up 16% year on year, with a 39.8% gross margin, 22.7% operating margin, 27.1% EBITDA margin, and net income attributable to HEICO of $690.4M (diluted EPS $4.90). Revenue has grown ~2.5x since FY2020, roughly half organic and half acquired.

The business splits into two segments. The Flight Support Group (FSG, ~69% of sales) is the commercial-aerospace-aftermarket engine: FAA-PMA (Parts Manufacturer Approval) replacement parts sold at ~25–50% below OEM spares, DER-engineered repairs, distribution (greatly expanded by the 2023 Wencor acquisition), and MRO. FSG posted its 21st consecutive quarter of sequential growth and a 26.2% operating margin in Q2 FY2026. The Electronic Technologies Group (ETG, ~31%) makes mission-critical defense, space, and other electronics (power conversion, RF/microwave, EMI shielding, memory) and is riding defense replenishment and the space-constellation build-out.

The competitive position is genuine but should be named precisely: HEICO’s moat is breadth + cost advantage + regulatory approval + trust, not the pricing-power monopoly that defines TransDigm. Its strongest structural protection is that OEMs cannot price-match HEICO’s discount without collapsing the spares margins that fund their whole business model. Capital allocation has been exceptional — a ~100-deal bolt-on machine, funded by ~$900M+ of annual free cash flow and modest leverage, that keeps subsidiary managers aligned through retained equity and put rights. The founder succession (Laurans Mendelson’s May 2025 transition to Executive Chairman and his death in September 2025) has resolved into a clean handoff to Co-CEOs Eric and Victor Mendelson.

The thesis tension is valuation, not quality. HEICO trades at ~30x EV/EBITDA and ~68x trailing earnings (on the Common), a ~40% EV/EBITDA premium to TransDigm despite materially lower margins and ROIC. On its own ten-year history it is mid-range (58th percentile), so there is no valuation cushion: the price underwrites mid-teens compounding and a continuing M&A perpetuity at scale. This memo takes no position and sets no price target; it lays out the embedded expectations, the scenarios, the falsification tests — and flags the HEI.A dual-class discount as the one structural inefficiency a careful investor can exploit.

2. Business Overview

What HEICO does. HEICO is a niche aerospace, defense, and electronics manufacturer built around two profit engines and a decentralized acquisition machine, headquartered in Hollywood, Florida, with ~10,000 employees. It was founded in 1957 (as Heinicke Instruments), renamed HEICO in 1986, and taken over by the Mendelson family in 1990 — the start of the modern compounding era. The company makes money two ways: by manufacturing and repairing parts that the world’s installed base of aircraft and electronic systems must consume regardless of new-build cycles, and by serially acquiring small, high-quality niche businesses and compounding their cash flows.

The two segments.

• Flight Support Group (FSG) — ~69% of FY2025 sales ($3,117M, +18% YoY), ~24% segment operating margin. FSG is the commercial-aftermarket engine and comprises three businesses: (1) the Parts Group — FAA-PMA replacement parts for jet engines and airframes; (2) Repair & Overhaul / MRO, including DER (Designated Engineering Representative) engineered repairs; and (3) Distribution, materially expanded by Wencor. FSG sells functionally identical alternatives to OEM spare parts at a deep discount — the razor-blade of commercial aviation. It logged its 21st consecutive quarter of sequential net-sales growth through late FY2025 and expanded its operating margin to 26.2% in Q2 FY2026 (from 24.1% a year earlier).
• Electronic Technologies Group (ETG) — ~31% of sales ($1,413M, +12% YoY), ~20% operating margin. ETG designs high-reliability electronic subcomponents — DC-DC power conversion, RF/microwave components and switches, EMI/RFI shielding, high-voltage connectors, memory, and laser/ISR electronics — sold mostly into defense, space, and aerospace (~80%), with a tail of medical, telecom, and industrial. ETG is more bespoke and program-tied than FSG, with a weaker (non-PMA) moat but strong secular end markets. In Q2 FY2026 ETG net sales rose 56% (17% organic plus acquisitions) and operating income 34%.

The aftermarket razor-blade economics. The core of the FSG thesis is the installed base. Aircraft and engines fly for 25–30+ years and must be maintained continuously; every flight hour consumes parts and repairs. HEICO reverse-engineers an OEM part, secures FAA-PMA approval that it meets or exceeds the original specification, and sells it for ~25–50% less — capturing high-margin spares revenue that would otherwise belong to the OEM. HEICO holds 19,500+ approved PMA part numbers and adds 500+ per year (up from ~5,000 in 2010 and ~11,000 in 2019). The catalog itself compounds: each new approval is a small, durable annuity.

Decentralized structure and family control. HEICO operates through 100+ subsidiaries run as standalone units with their own management. It typically buys ~80% of a target and leaves the operators with the rest, preserving entrepreneurial incentives. The company is run by Co-CEOs Eric A. Mendelson (who leads FSG) and Victor H. Mendelson (ETG), following the death of their father, founder/Chairman Laurans Mendelson, in September 2025. The dual-class structure (Common HEI vs. Class A HEI.A) concentrates voting control in the family.

Verdict. A high-quality, two-engine business: a structurally advantaged aftermarket franchise plus a proven acquisition flywheel, run by an aligned owner-operator family. The economics — ~40% gross margin, ~27% EBITDA margin, ~20% ROE, light capital intensity — confirm the quality.

3. Industry Dynamics

The commercial aerospace aftermarket is one of the best profit pools in industrials. Independent-aftermarket revenue is estimated at ~$89B in 2025, and the global MRO market is projected to reach ~$121B by 2030 (~4.75% CAGR). The demand driver is installed-base flight hours, not new-aircraft deliveries — which makes the aftermarket far less cyclical than OEM production and structurally high-margin. Two tailwinds are unusually strong now:

1. Aging fleets. More than 65% of in-service commercial aircraft are over 15 years old. Boeing and Airbus delivery shortfalls (737 MAX certification, supply-chain constraints, Pratt GTF powder-metal issues) are forcing airlines to fly older aircraft longer and spend more on heavy maintenance and components — directly expanding HEICO’s addressable base.
2. Post-pandemic flight-hour recovery and deferred-maintenance catch-up.

Why the aftermarket is structurally great. OEMs (GE Aerospace, RTX/Pratt, Safran, Honeywell, Rolls-Royce) sell engines and airframes at thin or negative margins precisely to capture decades of high-margin spares and service — the classic razor/razor-blade. HEICO inserts itself into that blade revenue as the low-cost alternative. Because demand is tied to the existing fleet rather than new production, the aftermarket smooths through OEM down-cycles. Through the Marathon capital-cycle lens, the aftermarket profit pool is fenced off from the capital-destroying boom/bust of new-aircraft manufacturing — a rare structural protection.

The PMA regulatory regime is the barrier. An operator can only install OEM or PMA-certified parts and retain airworthiness. FAA-PMA approval requires proving — through substantial engineering and testing — that a part meets or exceeds OEM specs, a slow, expensive, expertise-intensive process further throttled by FAA resource constraints. Beyond the FAA gate, each part must clear a separate airline/lessor/operator acceptance cycle that is relationship- and trust-driven. This dual gating is both the barrier to entry that protects HEICO and the reason any single part ramps slowly.

ETG’s end markets. Defense replenishment and sustainment (depleted munitions and platform stocks, F-15EX, F-16 Block 70), allied defense-budget increases, and space — both traditional and “new space” constellation deployment (Starlink, Kuiper, OneWeb) — are the key drivers. Management on the Q2 FY2026 call described defense orders “at record or near-record levels” and space “rocketing ahead.”

Verdict: structurally attractive — among the best industry structures in industrials. Recurring, high-margin, regulatorily fenced, counter-cyclical to OEM production, with secular defense/space tailwinds in ETG. The honest caveats: aftermarket demand is exposed to a severe air-travel shock (HEICO revenue fell ~13% in FY2020), and part of the current aging-fleet tailwind reverses if Boeing/Airbus deliveries normalize and airlines refresh fleets. But the base rate of the industry is excellent.

4. Competitive Position — and the TransDigm Contrast

HEICO and TransDigm are the two great aerospace-aftermarket compounders, with opposite moats. This is the single most important framing for the thesis, and it cuts against a naïve “HEICO is the cheaper-quality version of TransDigm” read.

• TransDigm (TDG): proprietary, sole-source OEM parts (>90% of sales), priced at OEM levels or higher with relentless annual increases; ~54% EBITDA margins; aggressive leverage (~5–7x); larger, less frequent deals. TDG’s moat is pricing power on parts no one else is allowed or economically motivated to make (most cost under $5,000 — too small for a PMA challenger to bother).
• HEICO: the low-cost PMA insurgent undercutting OEM spares by 25–50%; ~27% EBITDA margin; conservative leverage (~1.6x); frequent small bolt-ons. HEICO’s moat is cost advantage + regulatory-approval breadth + trust — it deliberately captures less margin than the OEM, because the discount is the product.

Naming HEICO’s moat (Greenwald taxonomy). HEICO’s advantage is a hybrid of (a) intangible/regulatory barriers — the FAA-PMA approval portfolio of 19,500+ parts, each a fenced micro-franchise built with engineering and certification time; (b) a genuine cost advantage — it reverse-engineers a part at a fraction of OEM original-development cost, so it can profitably sell at a deep discount; © reputation/trust — ~75 million parts shipped with zero airworthiness directives or in-flight shutdowns, the credential that gets a part through airline acceptance; and (d) the decentralized acquirer culture that lets it keep buying niche franchises cheaply. The moat is not one durable monopoly; it is breadth, speed, and trust across thousands of individually-modest part franchises.

Pressure-testing — and stating the bear case plainly.

• Why don’t OEMs just cut prices to kill PMA? Because aftermarket spares are the OEM’s entire profit pool — engines and airframes are sold at little or no margin to win the installed base. Matching HEICO’s discount on the small slice of parts HEICO attacks would risk collapsing pricing across the OEM’s whole catalog. As one analyst put it, price-matching HEICO “would be suicide.” This is the strongest pillar of the thesis: the incumbent’s own economics deter retaliation, and in downturns cost-pressured airlines move toward PMA — HEICO is counter-cyclically advantaged.
• The real threats (do not understate them). (1) OEM defensive tactics: “rolling dash numbers” (changing part specs to invalidate a PMA), bundling parts into system-level assemblies that aren’t individually replaceable, and lease/lessor contract terms requiring OEM parts — increasingly common and a genuine cap on PMA penetration. (2) No patents — HEICO’s PMAs are not IP-protected; the defense is speed and breadth, so competition exists per-part. (3) Architectural drift — modern aircraft have fewer, more-integrated, digital components, slowly shrinking the count of discrete, reverse-engineerable parts over decades.
• Durability vs TDG. TransDigm’s per-part moat is deeper (true sole-source pricing power); HEICO’s is broader but shallower per part — offset by far lower retaliation risk and a large remaining runway (HEICO penetrates only a low-single-digit percentage of the PMA-able parts universe). ETG has the weaker moat of the two segments: a conventional defense-electronics market where HEICO competes on engineering, reliability, and program incumbency against Curtiss-Wright, Mercury, Crane, Moog, and Woodward.

Switching costs. Modest but asymmetric. Once an airline qualifies a HEICO PMA part into its maintenance program (engineering review, internal approval, fleet-wide adoption), it is sticky — re-qualifying back to the OEM or to a rival offers no cost saving and adds friction. The qualification barrier works for HEICO once it is on the inside.

Verdict: a durable but breadth-based moat, not a TransDigm-style pricing monopoly. The advantage is real and visible in the financials (26.2% FSG operating margin, ~20% ROE), and is structurally hard to attack because OEM retaliation is self-destructive. But it is a portfolio of thousands of shallow franchises defended by speed and trust, not patents, and OEM countermeasures are a real, ongoing tax on penetration. The moat protects the economics; it does not, by itself, justify any particular multiple.

5. Growth History and Forward Opportunities

The historical record. Revenue compounded from $1,787M (FY2020) to $4,485M (FY2025) — roughly a 20% CAGR over five years — and net income from $314M to $690M. The engine is a two-part algorithm: double-digit organic growth plus continuous bolt-on M&A.

Organic vs acquired — and it is accelerating. FY2025 organic growth was FSG +14% / ETG +7%. Q2 FY2026 shows acceleration: FSG +19% organic, ETG +17% organic, with consolidated net income +49%, operating income +41%, and net sales +25% — all record results. This is unusually strong organic momentum for a serial acquirer and confirms that the organic engine, not just M&A, is firing (record or near-record orders across commercial aero, defense, and space). A notable margin mechanic: populating component repairs with HEICO’s own PMA parts means “less top line but more bottom line” — a margin-accretive mix shift visible in FSG’s expansion to 26.2%, helped by very low fixed costs and falling G&A as a percentage of sales.

FSG organic drivers: flight-hour growth on an aging, under-supplied fleet; 500+ new PMA approvals per year; share gains as cost-pressured airlines adopt PMA/DER; and Wencor-enabled distribution and repairs. ETG drivers: defense replenishment and allied budget increases, plus the space-constellation build-out. (Note: AI/data-center power, sometimes cited as an ETG driver, was not corroborated by HEICO disclosure — treat as unverified.)

The Wencor deal. ~$2.05B in 2023 (cash plus Class A stock), HEICO’s largest ever, at roughly ~13x EBITDA. It materially expanded the PMA portfolio, distribution network, and accessory-repair capabilities, and by 2025 was fully integrated into FSG with margins expanding, not diluting — the proof point that HEICO can absorb a large deal without breaking its model.

The bolt-on cadence continues. FY2025/2026 deals include Gables Engineering (avionics, ETG), Rosen Aviation (cabin electronics), Millennium International (90%, business-jet avionics MRO, FSG), Marway (92.5%), and a Honeywell avionics license — with four more bolt-ons announced by mid-FY2026 (Sherwood Avionics, Southwest Antennas, Cook Defence, CalRamic), all on the signature 80–90% structure. Management describes an “excellent acquisition pipeline, both large and small.”

The serial-acquirer runway. HEICO has completed ~100 acquisitions since 1990, sold only two businesses ever (“owning forever”), and sources from the fragmented long tail of family-owned aerospace/defense/electronics suppliers — where its reputation as a permanent, hands-off home is itself a sourcing edge. Returns on incremental capital have historically run ~20%.

Verdict: high-quality, durable, currently accelerating growth — but the valuation underwrites permanence of both legs. Organic growth is genuine and broad-based; M&A is disciplined and accretive. The skeptic’s note: the premium multiple bakes in continuation of both the M&A cadence and the current aftermarket up-cycle. Two risks to that — the aging-fleet tailwind partly reverses if OEM deliveries normalize (pulling FSG organic toward mid-single digits), and the bolt-on model requires an endless supply of reasonably-priced niche targets as the base grows ever larger. Neither is breaking now (organic is accelerating), but both are embedded assumptions, not certainties.

6. Financial Quality

Revenue, margins, and operating leverage. FY2025 revenue $4,485M (+16%); gross margin 39.8%, operating margin 22.7%, EBITDA margin 27.1% — each up year on year. The five-year margin trend is stable-to-improving despite heavy M&A, which is itself a quality signal (acquired businesses are not diluting the model). Incremental operating margin was ~31% in FY2025, and the Q2 FY2026 prints (net income +49% on sales +25%) show the operating leverage of a low-fixed-cost base.

Cash generation and capital intensity. FY2025 operating cash flow was $934M and free cash flow ~$934M — capex is strikingly light at ~1.6% of revenue, confirming an asset-light, IP/approval/distribution business rather than a capital-hungry manufacturer. Cash conversion is excellent: operating cash flow / net income ran ~1.35x, i.e., earnings are over-backed by cash — the opposite of an aggressive-accounting flag. SBC is modest (~$34M).

Returns on capital — read them correctly. ROE is ~20.6% and rising; ROIC is ~13.1%. The gap, and ROIC’s seemingly modest level, is goodwill-and-intangible drag: goodwill ($3.66B) plus net intangibles ($1.47B) total ~$5.1B of the $8.5B asset base, the accumulated cost of 100 acquisitions. Returns on tangible operating capital inside the subsidiaries are far higher; the consolidated ROIC is depressed by the price paid to acquire those franchises. The important trend is that post-Wencor ROIC has recovered from 10.8% (FY2023) to 13.1% (FY2025) as the deal seasons — exactly the pattern you want.

Balance sheet. Cash $218M; total debt ~$2.59B (mostly the 5.250% Notes due 2028 and 5.350% Notes due 2033 issued for Wencor, plus a $1.3B revolver); net debt ~$1.95B, ~1.6x EBITDA — down from ~3x immediately post-Wencor. Tangible book is negative (goodwill exceeds equity), normal for a serial acquirer and not a solvency concern given the cash generation. One under-discussed item: the redeemable noncontrolling interests ($338M, with ~$95M potentially payable in FY2026 if put-right holders exercise) are a recurring, real claim on free cash flow that does not run through reported net income — headline EPS slightly flatters the cash truly attributable to HEICO shareholders.

Verdict: high financial quality with one accounting nuance. Stable-to-rising margins, light capital intensity, excellent cash conversion, disciplined leverage, and clean earnings quality. The two things to hold in mind: consolidated ROIC is structurally capped near the low-teens by acquisition goodwill (the price of the growth model), and the put-right liability quietly claims cash each year.

7. Capital Allocation

The model. HEICO is a disciplined serial bolt-on acquirer funded almost entirely by internal free cash flow plus modest, transiently-deployed leverage. FY2025 deployed $630M on acquisitions, $73M on capex, and ~$32M on dividends; the residual went to debt paydown. This is a reinvest-everything compounder — capital returns to shareholders are deliberately trivial (a ~4% dividend payout, the 94th consecutive semi-annual dividend, and essentially no buybacks; HEICO is in fact a small net issuer via options and deal currency).

The signature “managers keep equity” structure. HEICO frequently acquires ~80–92.5% of a target and leaves the founders/operators with the rest, recorded as redeemable noncontrolling interests carrying put rights priced at a formula tied to a multiple of future earnings. This is the alignment engine of the whole model: it converts acquired founders into owner-operators who are paid to grow the business they just sold, the put’s value rising with their own performance. Combined with extreme decentralization (a tiny corporate center; FSG and ETG run independently), it replicates a “federation of motivated owners” rather than a cost-stripping roll-up — the closest aerospace analog to the Berkshire/Constellation Software model.

M&A track record and discipline. HEICO’s normal diet is small bolt-ons, many per year, typically tens of millions each, bought below the multiples paid for scarcer large assets. The Wencor outlier (~$2.05B, ~13x EBITDA) was absorbed without breaking the margin model and is now accretive. Acquisition spend by year: $137M (FY21), $347M (FY22), $2,422M (FY23, Wencor), $219M (FY24), $630M (FY25). Leverage discipline is visible and repeated: lever up for a big deal, then aggressively pay down toward ~1–1.5x to rebuild dry powder.

Is the capital allocation intelligent? Emphatically yes. The long-run record — from ~$26M revenue and market cap in the early 1990s to ~$4.5B revenue and ~$39B market cap — is among the best in US industrials. The flywheel combines cheap, repeatable bolt-ons; the keep-equity alignment structure; ruthless leverage discipline; and near-total earnings retention into a high-return reinvestment runway. The only legitimate reservations are price discipline at scale (Wencor was the priciest, most concentrated bet and temporarily depressed ROIC) and the deferred put-right liability that quietly claims cash each year. As HEICO grows, it must deploy progressively more capital annually just to hold its growth rate — the law-of-large-numbers risk that the premium multiple most aggressively ignores.

Insider activity. The 169-filing Form 4 corpus is dominated by routine mechanics — annual option exercises (each Mendelson exercises 80,000 options each October), Leadership Compensation Plan and 401(k) allocations, and 10b5-1 planned sales (including Laurans Mendelson’s 56,300-share sale at ~$319 in July 2025, before his death). The one genuine discretionary open-market purchase was director Nandakumar Cheruvatath’s ~$1M buy at ~$245 in March 2026. Net read: neutral-to-mildly-positive; the family’s enormous economic stake is intact regardless of the option churn.

Verdict: A-grade capital allocation, now tested by scale. The model is proven and the alignment is genuine. The forward question is not whether management is skilled — it is whether the flywheel can keep turning at $5B+ of revenue without sacrificing return discipline.

8. Changes and Headwinds — Last Two Years

Founder succession — now realized. The dominant corporate change is the leadership transition. Laurans Mendelson moved from Chairman/CEO to Executive Chairman on May 1, 2025, with sons Eric and Victor Mendelson appointed Co-CEOs; he then died on September 27, 2025, and the brothers became Co-Chairmen and Co-CEOs. This is about as clean a founder succession as exists — pre-planned, internal, with two seasoned owner-operators already running the two segments. The market treated it as continuity, not rupture. The residual risks are the co-CEO/co-Chairman two-headed structure (potential for divided accountability) and the loss of the founder’s deal-sourcing judgment — risks that only reveal themselves in the M&A track record over years.

M&A and operating milestones. The Wencor integration completed successfully (margin-accretive by 2025); the bolt-on cadence continued (Gables, Rosen, Millennium, Marway in FY2025; four more by mid-FY2026). Net leverage fell from ~3x to ~1.6x. Q2 FY2026 delivered record results with accelerating organic growth (FSG +19% / ETG +17% organic). Defense and space orders are at record or near-record levels.

Headwinds to monitor. (1) The aging-fleet/aftermarket tailwind is partly cyclical — a normalization of Boeing/Airbus deliveries or an air-travel shock would pull FSG organic growth lower. (2) OEM countermeasures against PMA (dash numbers, system bundling, lessor OEM-parts mandates) are an ongoing cap on penetration. (3) Tariff/supply-chain and defense-budget timing risks. (4) The law-of-large-numbers challenge to the M&A flywheel. None is acute today.

Verdict: the changes net to strengthening the near-term thesis (record results, accelerating organic, clean succession) while leaving the medium-term questions (cycle durability, M&A at scale) open.

9. Risk Analysis (Risk Matrix)

The risk profile is asymmetric in character: the probability of business impairment is low (high-quality, diversified, cash-generative), but the probability of share-price impairment via multiple compression is meaningful, because the valuation prices in continued excellence with no margin of safety.

10. Valuation Discussion (Embedded Expectations)

Where the multiple sits. At HEI $331.61, market cap is ~$39.1B and EV ~$41.1B. Against TTM (through Q2 FY2026) EBITDA of ~$1.36B that is ~30x EV/EBITDA; against FY2025 EPS of $4.90, ~68x trailing P/E on the Common (~55x on consensus FY2026 EPS of ~$6.07); EV/TTM sales ~8.4x. These are premium-compounder multiples, not industrial multiples.

The peer screen — HEICO is not cheap versus its closest comp. On EV/EBITDA, HEICO (~30x) sits below Howmet (~42x), Curtiss-Wright (~35x), and Axon (~40x), roughly in line with GE Aerospace (~28x), and above TransDigm (~21x). The central comparison is TransDigm: TDG earns double HEICO’s EBITDA margin (~54% vs ~27%) on a deeper pricing-power moat, yet HEICO trades at a ~40% EV/EBITDA premium. A lower-margin, lower-ROIC business commanding a higher EV/EBITDA than the higher-margin peer is the screen’s key tension. What HEICO offers in return: a far cleaner balance sheet (~1.6x vs ~5.7x leverage), faster current organic growth, deep family alignment, and a less politically-contested moat (HEICO is the regulator- and customer-friendly cost-saver; TDG faces recurring DoD pricing-reform headlines). The premium is defensible as a quality-and-balance-sheet preference — but it is not a bargain.

The own-history paradox. On absolute metrics HEICO is very expensive; on its own ten-year history it is only mid-range (AZI composite 58th percentile; P/E 56th, P/B 53rd, P/S 64th), below its 2021 peak. This is not a contradiction but a regime: the market has paid a structural premium for HEICO for two decades because the business reliably converts retained cash into ~20% per-share compounding. The multiple is effectively a duration instrument on the growth algorithm — it never mean-reverts to the market as long as the earnings keep growing into it (cf. Constellation Software, TransDigm). The risk is the flip side: the 58th percentile means you are not buying at peak greed, but you are emphatically not buying cheap, and there is no trough multiple to cushion a disappointment.

Embedded expectations / reverse-DCF. To justify ~$41B of EV off ~$934M of current free cash flow, HEICO must grow enterprise free cash flow at roughly 13–16% per year for a decade, then fade to a terminal ~4–5%. That is a more demanding embedded bar than TransDigm required in its reverse-DCF (~8–11%) and sits in Howmet’s stretched band. Decomposed, the price underwrites: high-single-to-low-double-digit organic growth (the +17–19% Q2 prints are above-trend and partly cyclical; ~8–10% is the durable assumption); plus M&A adding ~5–8 points of revenue annually at HEICO’s historical mid-teens EBITDA multiples; plus stable ~27% margins and ~13% ROIC. The single most aggressive embedded assumption is that the acquisition flywheel keeps turning at scale — the market is pricing M&A as a perpetuity, not a finite runway.

Scenario analysis (illustrative; not a price target). Roughly 2–3 year horizon, on ~139.4M shares and ~$41B EV:

The asymmetry is unfavorable relative to TransDigm: HEICO’s bear case works mostly through multiple compression from a non-cheap base (closer to Howmet’s setup), so the downside (~−30%+) is multiple-driven and meaningful, while the upside requires both sustained mid-teens compounding and multiple persistence. That said, HEICO’s lower financial risk and faster current organic growth partly offset the thinner valuation cushion. (Per-share figures reference HEI; HEI.A, at its ~25% discount, shifts each row’s entry point and improves the return math proportionally — see §11.)

11. Variant Perception

What consensus believes. The sell-side is firmly constructive (≈23 analysts, ~15 Buy vs ~8 Hold, 0 Sell; average target ~$386, ~16% above the Common). Consensus accepts the moat, the model, and the family stewardship, and debates only the pace of organic growth and whether the premium multiple is sustainable. The standing view: a best-in-class serial-acquirer compounder worth paying up for; the multiple is “always high,” and that’s fine.

The strongest bull case. A rare, decentralized, founder-aligned compounding machine with two distinct moats, a balance sheet light enough to keep acquiring through any environment, near-zero capital intensity (~$934M FCF), and a re-accelerating organic profile (+17–19% organic, net income +49% in Q2 FY2026). At only the 58th percentile of its own history, you are buying a proven ~20% per-share compounder below its own peak greed — and through HEI.A you can buy it ~25% cheaper still.

The strongest bear case. You are paying ~30x EV/EBITDA / ~68x earnings — a non-cheap multiple with no cushion — for a business whose ROIC (~13%) and EBITDA margin (~27%) are materially below TransDigm’s, at a ~40% EV/EBITDA premium to TDG. The price embeds ~13–16% FCF compounding for a decade, which requires the M&A flywheel to keep turning at ever-larger scale (law of large numbers) and the aftermarket strength to prove structural rather than cyclical. Any organic deceleration plus an M&A drought triggers the double-hit of lower earnings and a de-rate (~−30%+).

The 3–5 assumptions that matter most: (1) M&A-flywheel durability at scale (the most aggressive embedded assumption); (2) aftermarket — structural or cyclical (is +17–19% FSG organic durable or a destocking-reversal that normalizes to ~6–8%?); (3) margin/ROIC stability as the business acquires larger, lower-margin units; (4) multiple persistence; (5) succession continuity under the Co-CEO structure.

Falsification tests. The bull thesis breaks if: two-plus consecutive quarters of FSG organic below ~6% and M&A spend falling well below the ~$600M/yr run-rate — the flywheel visibly stalling — or ROIC drifting below ~11% on dilutive deals. The bear thesis breaks if: organic holds low-double-digits with sustained sub-15x-EBITDA accretive M&A for several quarters, validating that the runway and pricing discipline are intact at scale.

The factor/momentum read. HEICO is the low-volatility quality-compounder archetype, not a momentum melt-up: beta 0.84, ~7% off its 52-week high, with exceptional long-term risk-adjusted returns (annualized: 10-year +25.5%, 5-year +17.6%, 3-year +26.4%) but modest recent raw moves (1-year +9.1%, 6-month +6.8%, 3-month +14.3%). (Note: the FactorsToday leaderboard reports an annualized “m3 +67.5%/Sharpe 1.5” — that is the trailing quarter’s ~+14% move annualized, not a +67% three-month gain; the raw 3-month return is +14.3%.) The +14% three-month bounce is a recovery off an air-pocket, not a parabolic chase. This is a quality/low-vol factor exposure, so the de-rating risk is less about a momentum unwind than about a crack in the growth narrative. Consensus is not obviously offsides on direction; if it is offsides anywhere, it is on the durability of the M&A perpetuity the multiple prices.

The HEI.A dual-class discount — the cleanest variant. HEICO’s two share classes carry identical economic claims — same dividend, same per-share earnings — differing only in votes (Common 1, Class A 1/10). Yet HEI.A trades at $247.09 versus HEI’s $331.61, a ~25% discount (P/E ~50x vs ~68x), at the wide end of its historical ~10–18% range. Given that the Mendelson super-voting structure makes a minority holder’s vote worthless in practice, an economic-only investor gives up nothing usable by owning HEI.A — and mechanically improves the entry multiple, the dividend yield, and every scenario’s return on the identical underlying cash flows. This does not change the business thesis; it changes the price paid for it, and it is the single most actionable inefficiency in the name.

12. Fact vs. Interpretation Table

13. Open Questions

1. Can the M&A flywheel keep turning at scale — deploying ~$600M–$1B+/year at mid-teens multiples accretively as the base grows toward $6B+ revenue? The central question for the whole thesis.
2. Is the current FSG organic strength (+17–19%) structural or cyclical? What is the durable run-rate when the aging-fleet tailwind normalizes?
3. Does ROIC keep recovering toward the high-teens as Wencor fully seasons, or does relentless goodwill accretion cap it near ~13%?
4. Co-CEO durability and the next-gen bench — does the two-brother structure preserve the founder’s deal discipline, and who follows (David Mendelson)?
5. Does the HEI.A discount persist or compress? A narrowing would add return for Class A holders; a widening is a risk to that specific entry.
6. Cumulative put-right cash drain — how large does the RNCI redemption claim grow as the subsidiary count rises?

14. What Must Be True

For the bull case (and its falsification test):

• Must be true: HEICO sustains low-double-digit-plus organic growth in FSG and ETG while continuing to deploy ~$600M+/year of bolt-on M&A at accretive, sub-15x-EBITDA multiples that hold consolidated ROIC at or above ~13% — i.e., the flywheel keeps turning at scale — and the market continues to award the structural premium multiple.
• Falsification test: Two-plus consecutive quarters of FSG organic decelerating below ~6% and M&A spend falling materially below the ~$600M/year run-rate, or ROIC drifting below ~11% on dilutive deals. Any of these signals the compounding algorithm — and the multiple resting on it — is breaking.

For the bear case (and its falsification test):

• Must be true: The aftermarket tailwind proves cyclical and FSG organic normalizes toward mid-single digits; the M&A flywheel slows or pays up as competition for aerospace assets intensifies; and the ~30x EV/EBITDA multiple compresses toward the cohort/TransDigm — delivering a ~30%+ de-rate from a base with no valuation cushion.
• Falsification test: Organic growth holds low-double-digits with sustained sub-15x-EBITDA accretive M&A for several quarters, demonstrating that both the demand and the deal runway are intact at scale — validating the perpetuity the multiple embeds.

The debate reduces to one question: can a proven ~20% compounder keep compounding at $5B+ of revenue, and will the market keep paying ~30x EBITDA for the privilege? The price requires “yes” to both, and pays little for being wrong — which is precisely why the ~25%-cheaper HEI.A share class is the rational way to express any constructive view.

15. Source Appendix

The full citation list follows below in the Source Appendix. Primary sources include: HEICO FY2025 Form 10-K and FY2026 10-Qs (CIK 0000046619); Q4 FY2025 8-K earnings release and Q2 FY2026 earnings-call transcript (2026-05-28, via ROIC.ai); the 2026 DEF 14A proxy; 8-Ks on the leadership transition and Laurans Mendelson’s passing; the Form 4 corpus; ROIC.ai financial data; AZI valuation/price data; FactorsToday factor data (leaderboard returns annualized — the m3 figure de-annualized to a +14.3% raw quarter); HEICO investor materials; and competitor/industry sources (TransDigm filings, Aviation Week MRO data, FAA-PMA references).

The body of this article takes no investment position and contains no price target; the sole exception is the labeled “Claude’s Take” opening block, which is the author’s own independent opinion.

APPENDIX A — Standard Diligence Questionnaire

HEICO Corporation (NYSE: HEI / HEI.A) | As-of 2026-06-14

Supplemental to the main article. Fact / Interpretation / Assumption labels applied where it matters.

General

What thoughtful questions have other investors asked about this company? The debate clusters on five points: (1) is the premium multiple (~30x EV/EBITDA, ~68x P/E) sustainable, or does HEICO eventually de-rate toward the cohort? (2) Is the current FSG organic strength (+17–19%) structural or a cyclical destocking-reversal? (3) Can the M&A flywheel keep turning accretively as the revenue base grows (law of large numbers)? (4) Has the founder succession (Laurans Mendelson’s death, Sept 2025) changed the capital-allocation culture? (5) Why does HEI.A trade ~25% below HEI for identical economics, and will the gap persist? The most sophisticated framing is HEICO-vs-TransDigm: opposite moats (cost-advantage PMA insurgent vs proprietary pricing power), with HEICO at a premium multiple despite lower margins.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Modestly elevated. FSG (~69% of sales) rides an above-trend commercial-aftermarket cycle (aging fleets, OEM delivery shortfalls forcing older aircraft to fly longer, post-COVID deferred-maintenance catch-up). Q2 FY2026 organic (+17–19%) is above the durable run-rate; a normalized ~8–10% is the right base assumption. ETG (defense/space) is on a secular up-cycle. Not a cyclical low. (Interpretation)

Driven by the external environment or internal actions? Both. External: flight-hour growth, aging-fleet dynamics, defense/space budgets. Internal: 500+ new PMA approvals/year, share gains via the cost-advantage model, ~100-deal M&A flywheel, and margin self-help (low fixed cost, falling G&A %). (Fact/Interpretation)

How stable are revenues? High stability — aftermarket parts/repairs are consumed continuously by the installed base, smoothing through OEM down-cycles. The tail risk is a severe air-travel shock (FY2020 revenue fell ~13%). (Fact)

Outlook for products/services? Strong near-term: record orders across commercial aero, defense, space; 21+ consecutive quarters of FSG sequential growth; full bolt-on pipeline. (Fact)

How big will this market be? Growing. Global MRO ~$121B by 2030 (~4.75% CAGR); independent aftermarket ~$89B (2025). Primarily global, US-centric customer base, with defense/space secular tailwinds. (Fact)

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Stable-to-slightly-more. The PMA niche has high regulatory barriers, but OEMs are deploying countermeasures (dash numbers, system bundling, lessor OEM-parts mandates). ETG is a conventional competitive defense-electronics market. (Interpretation)

How profitable is the business (ROIC, ROE)? ROE ~20.6%, ROIC ~13.1% (FY2025). ROIC is capped near the low-teens by acquisition goodwill ($5.1B of $8.5B assets); returns on tangible operating capital inside subsidiaries are far higher. Incremental operating margin ~31%. (Fact)

How profitable is the industry — barriers to entry? Very profitable aftermarket profit pool; high barriers (FAA-PMA approval, airline acceptance cycles, reputation). HEICO is the largest independent PMA maker. (Fact)

Can the business be easily understood? Yes — two clear engines (aftermarket parts/repair + serial M&A). The complexity is in the regulatory PMA process and the redeemable-NCI accounting. (Interpretation)

Can it be undermined by foreign low-cost labor? Not meaningfully — the barrier is FAA certification, airworthiness trust, and engineering, not labor cost. (Fact)

Do brands matter? Yes, in the trust sense — HEICO’s ~75M-parts-shipped, zero-airworthiness-directive record is the credential that gets a PMA part through airline acceptance. (Fact/Interpretation)

What is the nature of competition? FSG competes on cost (vs OEM spares) + breadth + approval speed + trust. ETG competes on engineering, reliability, and program incumbency. (Interpretation)

Customers’ switching costs? Modest but asymmetric — once a PMA part is qualified into an airline’s maintenance program, re-qualifying back to OEM offers no cost saving and adds friction. (Interpretation)

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? Yes — the PMA approval portfolio and the decentralized acquisition culture are internally generated and not fairly capitalized. (Interpretation)

Off-balance-sheet liabilities? The redeemable noncontrolling interest put rights (~$338M, ~$95M potentially payable FY2026) are on-balance-sheet but outside permanent equity and re-marked through equity, not net income — a real recurring claim on FCF that headline EPS doesn’t fully reflect. (Fact)

How conservative is the accounting? Reasonably conservative; cash conversion is strong (OCF/NI ~1.35x). The nuance is the RNCI put-right mechanics and a heavy (un-impaired) goodwill/intangible load. (Fact/Interpretation)

How CapEx-hungry is the business? Very light — capex ~1.6% of revenue. Asset-light IP/approval/distribution model. (Fact)

Capital Allocation & Management

How much FCF does the business generate, and how is it used? FY2025 FCF ~$934M, deployed primarily into acquisitions ($630M) and debt paydown; ~$32M dividend; no buybacks. Reinvest-everything compounder. (Fact)

Capital-allocation philosophy? Disciplined serial bolt-on M&A funded by FCF + modest leverage (delever-then-acquire), with subsidiary managers kept aligned via retained equity/put rights. Near-total earnings retention into a high-return runway. (Fact/Interpretation)

Significant acquisitions recently? Wencor (~$2.05B, 2023); Gables, Rosen, Millennium, Marway (FY2025); four more bolt-ons by mid-FY2026. ~100 deals since 1990; sold only two businesses ever. (Fact)

Buying back shares? No — a small net issuer (options + deal currency). (Fact)

Issuing large amounts of new shares to insiders? Modest SBC (~$34M); annual option exercises by the Mendelsons; Class A used as acquisition currency. Dilution is modest. (Fact)

Compensation policy of directors/management? Co-CEOs ~$13M each (FY2025), mostly options + deferred comp; metrics tied to cash flow, net income, operating income, revenues, EBITDA — aligned with the value-creation model. Reasonable for a ~$39B-cap top-decile compounder. (Fact/Interpretation)

Motivations of management? Founder-family owner-operators with enormous economic stakes and super-voting control; aligned with long-term compounding. Co-CEOs Eric (FSG) and Victor (ETG) Mendelson. (Interpretation)

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — a US C-corp with a dual-class structure: Common (HEI, 1 vote) and Class A (HEI.A, 1/10 vote). Identical economics across classes; HEI.A trades ~25% cheaper. Not an MLP/K-1. (Fact)

Dividend policy? Token — ~4% payout, 94th consecutive semi-annual dividend; the model is reinvestment, not income. (Fact)

How profitable is the business? ~40% gross, ~23% operating, ~27% EBITDA margins; ~20% ROE. (Fact)

Is net income diverging from cash from operations? Favorably — OCF/NI ~1.35x (cash exceeds earnings). The only offset is the RNCI put-right cash claim outside reported NI. (Fact)

Risks & Downside

What factors would cause the stock to decline? A growth wobble (FSG organic fading + M&A drought) triggering the double-hit of lower earnings and multiple de-rate; an air-travel/aftermarket shock; a large dilutive deal capping ROIC; OEM countermeasures eroding PMA penetration; or a general de-rating of premium compounders. Given no valuation cushion (58th-pctile own-history), downside is meaningful (~−30%+ in the bear). (Interpretation)

Risk of a catastrophic loss? Low — profitable, modestly levered (~1.6x), diversified, cash-generative. A catastrophic scenario would require an extreme safety/legal event (e.g., a PMA airworthiness failure damaging the trust franchise). (Interpretation)

Chance of a total loss? Very low. (Interpretation)

Recent News & Events

Has the business environment changed recently? Positively near-term — record Q2 FY2026 results (net income +49%), accelerating organic growth, record defense/space orders, full M&A pipeline. (Fact)

Significant acquisitions? Yes — four bolt-ons by mid-FY2026 (Sherwood, Southwest Antennas, Cook Defence, CalRamic), on top of FY2025’s Gables/Rosen/Millennium/Marway. (Fact)

Change in accounting policies? None material; the RNCI put-right mechanics are the standing nuance. (Fact)

Recent changes — management? Major — founder Laurans Mendelson moved to Executive Chairman (May 2025) and died (Sept 2025); sons Eric and Victor Mendelson are now Co-CEOs and Co-Chairmen. Pre-staged, clean internal succession. (Fact)

APPENDIX B — Source Appendix

HEICO Corporation (NYSE: HEI / HEI.A) | As-of 2026-06-14

Sources prioritized primary-first. All accessed 2026-06-14 unless noted. Third-party aggregated data (ROIC.ai, AZI, FactorsToday) reconciled to filings where material; management commentary treated as hypothesis and validated against filings/financials.

Primary — Company filings & disclosures

• HEICO FY2025 Form 10-K (fiscal year ended 2025-10-31; filed 2025-12), CIK 0000046619 — segment data, M&A notes, redeemable-NCI (Note 13), debt, goodwill/intangibles. Mirrored locally to output/HEI/sources/.
• HEICO Q2 FY2026 Form 10-Q (period ended 2026-04-30; filed 2026-05-29). https://www.sec.gov/Archives/edgar/data/46619/000004661926000016/hei-20260430.htm
• Q4 FY2025 earnings release (8-K Ex-99.1) — segment revenue/margins, FSG 21 consecutive quarters, organic growth. https://www.sec.gov/Archives/edgar/data/0000046619/000004661925000076/a10312025ex991earningsrele.htm
• Q2 FY2026 earnings-call transcript (2026-05-28, via ROIC.ai) — record net income +49% / operating income +41% / sales +25%; FSG margin 26.2%; ETG +56% sales / +34% OI (17% organic); incremental-margin/low-fixed-cost commentary.
• 2026 DEF 14A proxy (filed 2026-01-30) — compensation, metrics, family ownership, voting math, related-party items.
• 8-Ks: leadership transition (Laurans Mendelson → Executive Chairman, Eric & Victor → Co-CEOs, May 1 2025); Laurans Mendelson’s passing (2025-09-29).
• Form 4 corpus (CIK 46619, 169 filings) — insider transaction read (option exercises, LCP/401(k) allocations, 10b5-1 sales, the one open-market director buy).
• HEICO investor relations / Parts Group (19,500+ PMA parts, +500/yr). https://heico.com/parts-group/

Quantitative data feeds (third-party; reconciled to filings)

• ROIC.ai MCP — income statement, balance sheet, cash flow, profitability ratios, enterprise value, valuation multiples, transcripts. Primary quantitative source FY2020–2025 + TTM.
• EDGAR XBRL (data.sec.gov) — verified diluted EPS (FY2022 $2.55 / FY2023 $2.91 / FY2024 $3.67 / FY2025 $4.90) and net income attributable to HEICO (FY2023 $403.6M / FY2024 $514.1M / FY2025 $690.4M).
• AZI valuation_index — own-history percentiles (composite 58th; P/E 56th, P/B 53rd, P/S 64th). Price CSVs for HEI and HEI.A ($331.61 / $247.09 on 2026-06-12) — used for the dual-class discount and verified raw trailing returns (3-month +14.3%, 6-month +6.8%, 1-year +9.1%).
• FactorsToday API — loadings (Market 0.92, Aerospace & Defense 0.66, Industrials 0.50, Quality/LowVol/Dividend tilts; R² 0.40); leaderboard (returns annualized: 10-year +25.5%/yr, 5-year +17.6%, 3-year +26.4%, 1-year +9.1%; the m3 “+67.5% / 1.5 Sharpe” is the trailing quarter’s ~+14.3% move annualized, not a 3-month gain); beta 0.84, alpha +9.6%, ~7% off 52-week high; related-stocks (HEI-A twin, XAR/PPA/ITA/DFEN A&D ETFs, HWM).
• Sell-side consensus / multiples — stockanalysis.com (FY2026E revenue ~$5.28B, EPS ~$6.07; ~23 analysts, avg target ~$386); peer EV/EBITDA via valueinvesting.io / gurufocus (TDG ~21x, HWM ~42x, CW ~35x, GE ~28x, AXON ~40x).

Secondary — Industry & competitor

• Commercial aftermarket/MRO sizing — Aviation Week (commercial aero aftermarket 2025); Grand View Research / SNS Insider (MRO ~$121B by 2030; >65% of fleet >15 yrs old).
• HEICO/TransDigm moat contrast — Eagle Point Capital (“HEICO: Compounding Beast”); In Practise (PMA threats / dual-sourcing); Morningstar HEICO note.
• Recent deals — AviTrader (Gables, 2025-07); Aviation Week (Rosen Aviation via Mid-Continent Controls).
• FAA-PMA regulatory regime — FAA references; trade press.

Note on momentum data: the FactorsToday leaderboard returns are annualized at every horizon. The m3 “+67.5%” is the latest quarter’s ~+14.3% actual move (HEI ~$290 on 2026-03-12 → ~$332 on 2026-06-12) expressed on an annualized basis, reconciled against the AZI price CSV. The verified read used throughout: a low-beta (0.84) quality compounder, exceptional long-term risk-adjusted returns but modest recent raw moves, ~7% off its 52-week high.